Rakuten Medical, Inc.

San Diego, CA · Founded 2010 · CIK 0001595215 · Biotech · Private

Tumor-penetrating peptide (iRGD) combined with gemcitabine chemotherapy for pancreatic cancer treatment

rakuten-med.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$887M
16 Form D · Apr 2026
6 months since last filing
Contracts
—
No federal contracts on record
Patents
40
12 granted · 28 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$8,455,175
Private capital raisedForm D · SEC$4,249,999
Private capital raisedForm D · SEC$40,000,000
Private capital raisedForm D · SEC$15,079,974
Private capital raisedForm D · SEC$149,999,993
Private capital raisedForm D · SEC$99,999,997
Private capital raisedForm D · SEC$791,700
Private capital raisedForm D · SEC$90,000,000
Private capital raisedForm D · SEC$15,000,000
Private capital raisedForm D · SEC$166,010,712
Private capital raisedForm D · SEC$5,194,350
Private capital raisedForm D · SEC$70,000,000
Private capital raisedForm D · SEC$104,816,348
Private capital raisedForm D · SEC$4,161,200
Private capital raisedForm D · SEC$1,368,550
Private capital raisedForm D · SEC$111,522,289
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2384Stemsynergy Therapeutic——
2385HiberCell——
2386RaeSedo, LLC——
2387Rakuten Medical, Inc.—$887M
2388Avalo Therapeutics—$182M
2389MOCKV SOLUTIONS INC.——
2390SERPIN PHARMA, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 25 related persons
  • Abhijit BhatiaExecutive Officer
  • Merrill BielDirector · Executive Officer
  • David ChaoDirector
  • Mazen DarwazahDirector
  • Mazen DarwazehDirector
  • Carlos GarciaExecutive Officer
  • Miguel Garcia-GuzmanDirector · Executive Officer
  • Kentaro HyakunoDirector
  • Dana JohnsonExecutive Officer
  • Eiichi KagaDirector
  • Brenton KeathExecutive Officer
  • Hiroyuki KodamaExecutive Officer
  • Minami MaedaExecutive Officer
  • Agatha MartindaleExecutive Officer
  • Ann McGuireExecutive Officer
  • Hiroshi MikitaniDirector · Executive Officer
  • Maeda MinamiExecutive Officer
  • Hiroshi MoriDirector
  • Nitin NohriaDirector
  • Tiffany PiecewiczExecutive Officer
  • Scott SalkaDirector · Executive Officer
  • Suzane SanExecutive Officer
  • Toshiaki SuzukiExecutive Officer
  • Hiroshi TakasawaDirector
  • Takashi ToraishiDirector · Executive Officer

Patents

USPTO · 12 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.